How a century-old blood therapy turned into a new way to fight COVID-19

Last week the US Food and Drug Administration (FDA) approved the experimental use of blood from recovered COVID-19 subjects as a treatment for newly infected patients. Known as convalescent plasma therapy, the treatment harks back to the late 19th cent… Continue reading How a century-old blood therapy turned into a new way to fight COVID-19

Bacterial DNA signatures in blood point to new universal cancer test

Developing a simple blood test that can detect all kinds of early-stage cancers is something of a holy grail for many researchers. A huge variety of different blood-based cancer diagnostic methods are currently in development tracking everything from p… Continue reading Bacterial DNA signatures in blood point to new universal cancer test

Promising progress on blood and urine tests for prostate cancer

Two new studies are offering promising progress in the development of novel diagnostic tests to detect and monitor prostate cancer. The research presents a urine test that can detect the disease in its early stages and a blood test that may catch the c… Continue reading Promising progress on blood and urine tests for prostate cancer

Alzheimer’s blood test may replace invasive spinal taps for diagnosis

A new blood test could offer a new way of detecting Alzheimer's disease early on

Alzheimer’s disease is not an easy one to diagnose, with physicians relying on expensive PET scans and fluid sampling to make a decision on a patient’s wellbeing. Some exciting advances are being made when it comes to blood-testing, however, that could change the game by offering clearer insights into the disease during its earlier stages. The latest example of this offers a particularly promising pathway forward, with an ability to spot a traditionally hard-to-detect protein called tau, considered a key biomarker of the disease.

Continue Reading

Category: Medical, Science

Tags: , ,

Continue reading Alzheimer’s blood test may replace invasive spinal taps for diagnosis

Biomarkers pave way for blood test to predict Parkinson’s progression

Blood-based biomarkers could help predict the progression of Parkinson's disease

When Parkinson’s patients are diagnosed with the condition, there are still many unknowns around how the disease will develop and how it will impact their lives. While it is no crystal ball, a new blood test developed at Newcastle University and Cambridge University in the UK is offering hope of better patient management, with an ability to recognize early indicators of cognitive decline, dementia and progression of motor symptoms.

Continue Reading

Category: Medical, Science

Tags: , , , , ,

Continue reading Biomarkers pave way for blood test to predict Parkinson’s progression

Blood test to predict how likely you are to die within 5 to 10 years

A provocative new study is suggesting a blood test tracking 14 different biomarkers can predict a person’s risk of dying within the next 10 years better than any conventional models. The research is still a long way off being broadly deployed… Continue reading Blood test to predict how likely you are to die within 5 to 10 years

New breast cancer blood test 100 times more sensitive than similar tests

An extraordinarily sensitive new blood test has been developed that promises to be able to effectively track the progression of breast cancer at its earliest stages. It is suggested the blood test could track the efficacy of drug therapies be… Continue reading New breast cancer blood test 100 times more sensitive than similar tests

Gluten response biomarker offers potential new blood test to diagnose celiac disease

A new research breakthrough uncovering the very earliest inflammatory mechanism triggered in celiac sufferers after consuming gluten could lead to be novel blood test making it substantially easier for clinicians to diagnose the disease…
C… Continue reading Gluten response biomarker offers potential new blood test to diagnose celiac disease

Young blood cocktail stops Alzheimer's decline, early clinical trial reports

The company behind a Phase 2 trial of its proprietary young plasma protein formulation says it ...

Alkahest, a California-based biotech start-up, has just revealed some compelling early results from an ongoing Phase 2 trial into the efficacy of its novel formulation of plasma proteins derived from young blood, developed to slow, or even stop, the cognitive decline associated with Alzheimer’s disease.

..
Continue Reading Young blood cocktail stops Alzheimer’s decline, early clinical trial reports

Category: Medical

Tags:

Continue reading Young blood cocktail stops Alzheimer's decline, early clinical trial reports

Alzheimer’s blood test could replace PET brain scans after hitting 94 percent accuracy

A new blood test for Alzheimer's could enable the rapid screening of patients for clinical trials ...

A new study from scientists at the Washington University School of Medicine in St. Louis is suggesting a novel blood test can identify subjects at an early stage of Alzheimer’s disease, years before any symptoms appear. The blood test may even be more accurate than PET brain scans, and is hoped to accelerate screening of patients for participation in clinical trials.

..
Continue Reading Alzheimer’s blood test could replace PET brain scans after hitting 94 percent accuracy

Category: Medical

Tags:

Continue reading Alzheimer’s blood test could replace PET brain scans after hitting 94 percent accuracy